Hyperhomocysteinemia and risk for peripheral arterial occlusive disease in young women

Journal of Vascular Surgery

Volumn 38, Issue 4, 2003, Pages 772-778

  Van den Bosch, Maurice A A J ^a,b   Bloemenkamp, Daisy G M ^a,b   Mali, Willem P Th M ^b   Kemmeren, Jeanet M ^a   Tanis, Bea C ^c   Algra, Ale ^a   Rosendaal, Frits R ^c   Van der Graaf, Yolanda ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; ARTERY DISEASE; ARTERY OCCLUSION; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; PERIPHERAL CIRCULATION; POPULATION RISK; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKING; VEIN BLOOD FLOW;

EID: 0141954235     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00476-2     Document Type: Article

References (40)

1. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
2. Levy PJ, Gonzalez F, Hornung CA, Chang WW, Haynes JL, Rush DS. A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis. J Vasc Surg 1996;23:36-45.
3. Dormandy J, Heeck L, Vig S. Predictors of early disease in the lower limbs. Semin Vasc Surg 1999;12:109-17.
4. Aronow WS, Ahn C. Association between plasma homocysteine and peripheral arterial disease in older persons. Coronary Artery Dis 1998;9:49-50.
5. Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg 1997;11:217-23.
6. Van Guldener C, Stehouwer CDA. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 2000;26:281-9.
7. Vogt MT, Wolfsen SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992;45:529-42.
8. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997;2:221-6.
9. Kannel WB, Skinner JJ Jr, Schwartz MJ, Shurtleff D. Intermittent claudication: incidence in the Framingham study. Circulation 1970;41:875-83.
10. Cronenwett JL, Davis JT, Gooch JB, Garret HE. Aortoiliac occlusive disease in women. Surgery 1980;88:775-84.
11. Levy PJ, Hornung CA, Haynes JL, Rush DS. Lower extremity ischemia in adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease. J Vase Surg 1994;19:873-81.
12. Van Vroonhoven TJMV. Intermittent claudication in premenopausal women: a correlation with the long term use of oral contraceptives? J Cardiovasc Surg 1977;18:291-5.
13. Hoogeveen EK, Kostense PJ, Jakobs C, Rauwerda JA, Dekker JM, Nijpels G, et al. Hyperhomocysteinemia is not associated with isolated crural arterial occlusive disease: the Hoorn study. J Intern Med 2000;247:442-8.
14. Gagne PJ, Vitti MJ, Fink LM, Duncan J, Nix ML, Barnes RW, et al. Young women with advanced aortoiliac occlusive disease: new insights. Ann Vase Surg 1996;10:546-57.
15. Tanis BC, van den Bosch MAAJ, Kemmeren JM, Manger Cats V, Helmerhorst FM, Algra A, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001;345:1787-93.
16. van den Bosch MAAJ, Kemmeren JM, Tanis BC, Mali WPThM, Helmerhorst FM, Rosendaal FR, et al. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost 2003;1:439-44.
17. Willems HP, Bos GM, Gerrits WB, den Heijer M, Vloet S, Blom HJ. Acidic citrate stabilizes blood samples for assay of total homocysteine. Clin Chem 1998;44:342-45.
18. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
19. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
20. Van de Laak MF, van der Graaf Y, Banga JD, Simons PC, Algra A. Prevalence and treatment of hypercholesterolemia in patients with manifest vascular disease according to practice guidelines of current cholesterol consensus. Ned Tijdschr Geneeskd. 2000 Apr 8;144:706-9.
21. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993;39:263-71.
22. Poele-Pothoff MTWB, Van den Berg M, Franken DG, Boers GHJ, Jakobs C, De Kroon IFI, et al. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem 1995;32:218-20.
23. Rose GA, Blackburn H. Cardiovascular survey methods. East Afr Med J 1969;46:220-7.
24. Meijer WT, Grobbee DE, Hunnink MGM, Hofman A, Hoes AW. Determinants of peripheral arterial disease in the elderly. The Rotterdam Study. Arch Int Med 2000;160:2934-8.
25. Hansen ME, Valentine RJ, McIntire DD, Myers SI, Chervu A, Clagett GP. Age related differences in the distribution of peripheral atherosclerosis: when is atherosclerosis truly premature? Surgery 1995;118:834-9.
26. Van den Berg M, Stehouwer CDA, Bierdrager E, Rauwerda JA. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arterioscler Thromb Vasc Biol 1996;16:165-71.
27. The European Concorted Action Project. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997;277:1775-81.
28. Malinow MR, Kang SS, Taylor LM, Wong PW, Coull B, Inahara T, et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation 1989;79:1180-8.
29. Verhoeff P. Hyperhomocysteinemia and risk of vascular disease in women. Semin Thromb Haemost 2000;26:325-34.
30. Taylor LM, Moneta GL, Sexton GJ, Schuff RA, Porter JM. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 1999;29:8-21.
31. Van den Berg M, Boers GH, Franken DG, Blom HJ, Van Kamp GJ, Jakobs C, et al. Hyperhomocysteinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 1995;25:176-81.
32. Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993;13:1253-60.
33. Bauwens F, Duprez D, Van Wassenhove A, Brusselmans F, Clement DL. Localisation and risk factors of peripheral arterial occlusive disease in the female. Int Angiol 1989;8:32-5.
34. Bergmark C, Mansoor MA, Swedenborg J, de Faire U, Svardal AM, Ueland PM. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50: effect of smoking and extent of disease. Eur J Vasc Surg 1993;7:391-6.
35. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526-33.
36. Perry IJ. Homocysteine, hypertension and stroke. J Hum Hyperten 1999;13:289-93.
37. Socha MW, Polakowska MJ, Socha-Urbanek K, Fiedor P. Hyperhomocysteinemia as a risk factor for cardiovascular disease: the association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients. Ann Transplant 1999;4:11-9.
38. Rassoul F, Richter V, Janke C, Purschwitz K, Klotzer B, Geisel J, et al. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease. Angiology 2000;51:189-96.
39. Loncar R, Hrboka V, Tabakovic-Loncar V, Ostojic Z, Deussen A. Screening of plasma homocysteine in peripheral arterial disease. Ann Med 2001;33:48-54.
40. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta 1992;207:119-28.